What happens after patients ‘recover’ from COVID? Normal can be elusive

at main images online feature covid long haulers

Surviving Covid-19 is hard enough for those who get severely ill from the disease, but returning to normal is a struggle, too, according to new research that found survivors were likely to face health and financial hardships even months later.

A team of scientists led by Dr. Vineet Chopra of the University of Michigan Health System looked at 488 Covid-19 patients treated and released from hospitals in Michigan. They surveyed them about two months after their release, between March 16 and July 1.

A third of the survivors reported ongoing health issues, such as cough, new or worsening conditions and persistent loss of taste or smell, the researchers reported this week in the journal Annals of Internal Medicine.

Nearly half said they were “emotionally affected” by their illness and a small number, 28, sought mental health care after discharge.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

Of those employed before their illness, 40% said they either lost their job or were too sick to return to work. Just over a quarter of those who returned to work reported reduced hours or modified responsibilities.

“For most patients who survived, ongoing morbidity, including the inability to return to normal activities, physical and emotional symptoms, and financial loss, was common,” Chopra’s team wrote.

“These data confirm that the toll of Covid-19 extends well beyond hospitalization,” the study concluded.

Read the original post

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Crumbling MAHA Stage Portrait
Cataloging the RFK Jr.-MAHA crushing midterm collapse
Microscopic IVF Egg Injection
With technical barriers to human embryo editing falling, ethical concerns escalate
Blue Checklist in Centered Hand
Viewpoint: From Medicaid cuts to MAHA-backed anti-vaccine and chemical hysteria, voters reject Republicans’ science-skeptical agenda
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Hipster eugenics: better babies for billionaires
Viewpoint: “Positive eugenics”: Reviving a movement reviled and condemned for a century
Reaching Through the Woven Sky
Challenging genetic modification rejectionists: Our evolving food system has relied on science for thousands of years
Picture1
Viewpoint: How badly is the U.S. food-safety net fraying? FDA’s bungled handling of the tainted lettuce crisis deepens concerns over cuts to disease tracking and response
Screenshot 2026-11-04 at 12.02
Ever wonder why AI can so easily be duped into manufacturing health misinformation?    
Bayer Crop Circle in Golden Wheat
Making fertilizer from thin air: Bayer’s gene-editing innovation could dramatically cut chemical fertilizer use in growing food
Smiling-Woman-Over-Teal-Abstract-Shapes
Viewpoint: RFK Jr.’s latest foray into junk science: Even Kennedy’s hand-picked NIH director balks at appointment of crackpot mental health director
Screenshot-2026-10-29-at-11.18.34-AM
Viewpoint: ‘Just the flu’: Skipping your child’s flu shot could be a fatal mistake
Screenshot-2026-11-02-at-11.34.28-AM
Farmers are collateral damage in the PFAS “forever chemicals” crossfire. Here’s what they need to know.
Neon Genome_ Fetal Dreamscape
The race to genetically engineer babies
Screenshot-2026-10-28-at-3.00.44-PM
Viewpoint: Activist attacks on corporations increasingly depend on "attribution" science to target oil companies for global climate change
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.